IT1170235B - Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare - Google Patents

Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare

Info

Publication number
IT1170235B
IT1170235B IT23559/83A IT2355983A IT1170235B IT 1170235 B IT1170235 B IT 1170235B IT 23559/83 A IT23559/83 A IT 23559/83A IT 2355983 A IT2355983 A IT 2355983A IT 1170235 B IT1170235 B IT 1170235B
Authority
IT
Italy
Prior art keywords
cardiac
metabolic
pharmaceutical composition
energy action
vascular therapy
Prior art date
Application number
IT23559/83A
Other languages
English (en)
Italian (it)
Other versions
IT8323559A0 (it
Inventor
Alberto Bertelli
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Publication of IT8323559A0 publication Critical patent/IT8323559A0/it
Application granted granted Critical
Publication of IT1170235B publication Critical patent/IT1170235B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT23559/83A 1983-02-16 1983-10-31 Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare IT1170235B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH858/83A CH655005A5 (it) 1983-02-16 1983-02-16 Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Publications (2)

Publication Number Publication Date
IT8323559A0 IT8323559A0 (it) 1983-10-31
IT1170235B true IT1170235B (it) 1987-06-03

Family

ID=4196830

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23559/83A IT1170235B (it) 1983-02-16 1983-10-31 Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare

Country Status (11)

Country Link
US (1) US4599232A (enExample)
JP (1) JPS59186914A (enExample)
BE (1) BE898918A (enExample)
CH (1) CH655005A5 (enExample)
DE (1) DE3405581A1 (enExample)
DK (1) DK165167C (enExample)
FR (1) FR2543827B1 (enExample)
GB (1) GB2137088B (enExample)
IT (1) IT1170235B (enExample)
NL (1) NL192778C (enExample)
SE (1) SE457143B (enExample)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209519B (it) * 1984-04-10 1989-08-30 Poli Ind Chimica Spa Composti ad attivita'cardiotrofica.
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
CH670763A5 (enExample) * 1985-08-02 1989-07-14 Seuref Ag
CH666183A5 (it) * 1985-08-06 1988-07-15 Seuref Ag Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
IT1184655B (it) * 1985-10-14 1987-10-28 Sigma Tau Ind Farmaceuti Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock
SE8703321D0 (sv) * 1987-08-27 1987-08-27 Sockerbolaget Ab Kostforsterkning
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
GB8907276D0 (en) * 1989-03-31 1989-05-17 Therapy Advisory Services Limi Health supplement
AT393954B (de) * 1990-02-28 1992-01-10 Bock Orthopaed Ind Verfahren und vorrichtung zur bestimmung von gebrauchseigenschaften eines prothesenschaftes
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
DK0643775T3 (da) * 1992-05-28 2004-09-06 Ct For Molecular Biology And M Quinonderivater til forbedring af cellebioenergi
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
WO1998043617A2 (en) * 1997-03-27 1998-10-08 Sole Michael J Nutritional composition for improvements in cell energetics
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
US5889055A (en) * 1997-04-04 1999-03-30 Howard; James R. L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
AU3221599A (en) * 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US20050196470A9 (en) * 1998-04-03 2005-09-08 Wuh Hank C Method and composition for enhancing sexual desire
US7371415B1 (en) 1998-04-03 2008-05-13 The Daily Wellness Company Method and composition for improving sexual fitness
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
AU7828200A (en) 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
US20070072927A1 (en) * 1999-09-23 2007-03-29 Vita Joseph A Nutritional supplement for increased energy and stamina
EP1248609A4 (en) 1999-11-03 2007-08-01 Juvenon Inc METHOD FOR TREATING THE GOOD MEMORY TROUBLESHOOTING
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6740338B1 (en) 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
US20010043983A1 (en) * 2000-01-25 2001-11-22 Hamilton Nathan D. Nutritional supplements for aged pets
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
US6441050B1 (en) 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6497885B2 (en) 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US6579866B2 (en) 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
US20060062864A1 (en) * 2000-12-28 2006-03-23 Mccleary Edward L Weight loss composition and method
KR100685696B1 (ko) * 2001-05-10 2007-02-23 카네카 코포레이션 활성 성분으로 조효소 ｑ를 함유하는 경점막 투여용 조성물
WO2003002147A1 (en) * 2001-06-28 2003-01-09 Takeda Chemical Industries, Ltd. Preventives/remedies for organ functional disorders and organ dysfunction
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
EP1875816A3 (en) * 2003-07-10 2008-03-12 Carl A. Forest Beverages with specialized supplements
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8105583B2 (en) * 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN101022793B (zh) * 2004-06-29 2011-05-11 美国益力斯林公司 用以促进新陈代谢和降低活性氧水平的食品组合物
PT2471530T (pt) * 2005-06-01 2017-04-19 Edison Pharmaceuticals Inc Produtos terapêuticos com atividade redox para o tratamento de doenças mitocondriais e de outras condições e modulação de biomarcadores energéticos
US20050249803A1 (en) * 2005-06-03 2005-11-10 Udell Ronald G Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
JP2009508867A (ja) * 2005-09-15 2009-03-05 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
TW200735863A (en) * 2006-01-13 2007-10-01 Elixirin Corp Dietary compositions for enhancing metabolism and reducing reactive oxygen species
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
US20080020022A1 (en) * 2006-06-05 2008-01-24 Udell Ronald G Chewable co-enzyme q-10 capsule
US7615324B2 (en) * 2007-03-14 2009-11-10 Fujifilm Corporation Photosensitive composition, and cured relief pattern production method and semiconductor device using the same
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
ES2306610B1 (es) * 2007-04-16 2009-09-11 Universidad De Sevilla Uso de la l-carnitina para el tratamiento de la hipertension arterial.
EP2172196B1 (en) * 2007-06-22 2020-03-25 Kaneka Corporation Composition containing coenzyme q10
EP2172223B1 (en) * 2007-06-22 2020-12-16 Kaneka Corporation Composition containing physiologically active substance
WO2009025277A1 (ja) * 2007-08-22 2009-02-26 Kaneka Corporation 還元型補酵素ｑ10の製造方法、ならびに、その安定化方法
CN101951930A (zh) * 2008-02-19 2011-01-19 阿奈斯特药品株式会社 对身体功能的恢复有用的口服或经肠组合物
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene

Also Published As

Publication number Publication date
US4599232A (en) 1986-07-08
FR2543827B1 (fr) 1987-06-12
CH655005A5 (it) 1986-03-27
DK72284A (da) 1984-08-17
DE3405581C2 (enExample) 1992-10-22
DK165167B (da) 1992-10-19
IT8323559A0 (it) 1983-10-31
NL192778B (nl) 1997-10-01
DK72284D0 (da) 1984-02-16
NL192778C (nl) 1998-02-03
GB8403668D0 (en) 1984-03-14
DK165167C (da) 1993-03-01
JPH027572B2 (enExample) 1990-02-19
GB2137088A (en) 1984-10-03
FR2543827A1 (fr) 1984-10-12
BE898918A (nl) 1984-08-16
DE3405581A1 (de) 1984-10-18
JPS59186914A (ja) 1984-10-23
GB2137088B (en) 1986-02-05
SE8400851D0 (sv) 1984-02-16
SE8400851L (sv) 1984-08-17
NL8400488A (nl) 1984-09-17
SE457143B (sv) 1988-12-05

Similar Documents

Publication Publication Date Title
IT1170235B (it) Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare
ES537769A0 (es) Protesis cardiaca total que incluye dos bombas desacopladas asociadas en una unidad funcional indisociable
IT1209663B (it) Derivati eterociclici aromatici eloro applicazione nei settori terapeutico e cosmetico.
IT1140040B (it) Derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia
SE7808768L (sv) Konstgjord klaff for att ersetta mitral- och tricuspidalklaffen i menniskohjertan
IT1168074B (it) Derivati amminoalchil-eterociclici, loro procedimento di preparazione e loro applicazione in terapia
IT8348746A0 (it) Derivati amminometil-benzenici arilsostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni che li contengono
FI841513A7 (fi) Perfluorihiilivetyemulsiot sekä niiden valmistus ja käyttö terapiassa
OA07412A (fr) Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique.
FI843005A7 (fi) 1,6-naftyridioni-johdannaiset, niiden valmistusmenetelmä ja käyttö suonisairauksien estossa
FI954138L (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
FI883483A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja käyttö terapiassa
FI910924A7 (fi) Uusia propanamiineja, niiden valmistus ja niiden käyttö terapeuttisiintarkoituksiin, erityisesti ripulilääkkeenä
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
IT1096906B (it) Derivati di 1,2,4-ossadiazolo,loro preparazione e loro applicazione in terapia
FI883484A7 (fi) Bentsimidatsolijohdannaiset, niiden valmistus ja käyttö terapiassa.
IT1153062B (it) Derivati benzilidenici, loro preparazione e loro applicazione in terapia
IT8621394A0 (it) Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
IT8648189A0 (it) Benzammidi, loro procedimentodi preparazione e loro applicazione in campo terapeutico
IT1059875B (it) Benzodiossani 1..4 loro procedimento di preparazione e loro applicazione in terapia
IT1176041B (it) Difenilazometine sostituite, loropreparazione e loro impiego in terapeutica
IT1176042B (it) Difenilazometine idrossilate, loropreparazione e loro impiego in terapeutica
MD47B1 (ro) Remediu ce stimuleaza lucrul cordului in timpul experientei
IT1188704B (it) Derivati insaturi cicloalifatici,loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica
IT7921794A0 (it) Esteri benzilidenici e loro impiego in terapeutica.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029